Institute of Biomedical Research Corp.
MRES · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.8% | 53.1% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43.2% | 19% | 29.5% | – |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,463.5% | 3,091.4% | -1,304.5% | – |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,278.6% | 2,950.3% | -1,472% | – |
| EPS Diluted | -0 | 0.001 | -0 | -0 |
| % Growth | -133.3% | 300% | -50% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |